Top View
- Synergy and Duality in Peptide Antibiotic Mechanisms Dewey G Mccafferty*, Predrag Cudic, Michael K Yu, Douglas C Behenna and Ryan Kruger
- DRIVE-AB REPORT Revitalizing the Antibiotic Pipeline
- Antibiotic Use and Antibiotic Resistance: Answers for Patients
- Performance of the Belgian Health System – Report 2019 – Supplement
- Annual Report of Antibiotic and Antimycotic Consumption 2019
- Beta-Lactam Allergy Tip Sheet
- Cyclic Antibiotic Peptides
- Antibiotic-Overview.Pdf
- Antibiotics & Common Infections
- The Decrease in Antibiotic Funding
- Antibiotics Made Easy
- Nosopharm and Evotec Enter Into Collaboration to Accelerate Development of Novel Antibiotics
- Antibiotics: Frequently Asked Questions
- A4 - a NOVEL PEPTIDE ANTIBIOTIC ID: 4006 Featured Innovators: Y
- Penicillin…He Will Come Home!” the Challenge of Mass Production
- AAE Guidance on the Use of Systemic Antibiotics in Endodontics
- Group 5 Drugs for Multidrug-Resistant Tuberculosis: Individual Patient Data Meta-Analysis
- Antibiotics Aren't Always the Answer
- Antibiotic Discovery: History, Methods and Perspectives
- Polymyxins and Bacterial Membranes: a Review of Antibacterial Activity and Mechanisms of Resistance
- Alterins Produced by Oyster-Associated Pseudoalteromonas Are Antibacterial Cyclolipopeptides with LPS-Binding Activity
- Targeting Innovation in Antibiotic Drug Discovery and Development (2016)
- Brilacidin First-In-Class Defensin-Mimetic Drug Candidate Background and Scientific Rationale for Brilacidin As a Potential Novel Coronavirus (COVID-19) Treatment
- Antibiotic Consumption in Hospitalized Children at the University Clinic for Pediatric Diseases – Skopje
- Beta-Lactam Antibiotics and Vancomycin
- You've Been Prescribed an Antibiotic in the Hospital for an Infection
- UK Veterinary Antibiotic Resistance and Sales Surveillance Report, 2012.’ VMD
- Gary Zagami, Et Al. V. Cellceutix Corporation, Et Al. 15-CV-07194-Second Amended Class Action Complaint for Violations of Federa
- A Review on Β-Lactam Antibiotic Drug Resistance
- Malacidins: a Newly Discovered Class of Antibiotics from Soil Microbiome Inside This Issue
- Brilacidin, a COVID-19 Drug Candidate, Exhibits Potent in Vitro Antiviral Activity Against SARS-Cov-2
- Supplementary Material UK-VARSS 2019
- Thenoic Acid Cross-Resistance Occurs Between Thiamphenicol and Chloram- Reactions Associated with Thioacetazone
- Is It Really a Penicillin Allergy?
- WHO Methodology for a Global Programme on Surveillance of Antimicrobial Consumption
- An Activist's Guide to Tuberculosis Drugs 2016 Update
- Sarecycline Interferes with Trna Accommodation and Tethers Mrna to the 70S Ribosome
- Thiacetazone | Medchemexpress
- Two Distinct Amphipathic Peptide Antibiotics with Systemic Efficacy
- Odilorhabdins, Antibacterial Agents That Cause Miscoding by Binding at a New Ribosomal Site
- The Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance In
- New FDA Approved Antibacterial Drugs: 2015-2017
- New Antimicrobials Brilacidin, Host Defence Peptide Mimetic, One of a New Class of Immunomodulatory Agents That Can Target Multiple Disease Indications
- Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics
- Mycobacterial Cell Wall: a Source of Successful Targets for Old and New Drugs
- Penicillin Allergy 101 for Nurses
- Antibacterial Drugs: Discovering Antibiotics Through Soil Metagenomics
- The Clinical Potential of Antimicrobial Peptides
- ICD-10-CM Table of Drugs 2019
- Sales of Veterinary Antimicrobial Agents in 31 European Countries in 2018
- Brief Original Article Antibiotic Use in Albania Between 2011 and 2012
- Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant Pseudomonas Aeruginosa and Minimize Biofilm Formation
- An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group
- When Do You Need an Antibiotic?
- Beta Lactam Antibiotics, Structural Analogs of the D-Ala-D-Ala Substrate, Bind to Active Site of PBP
- Antibiotic Resistance in People with Cystic Fibrosis
- Life Antibiotic Use, Asthma and Eczema
- Effect of Polymyxin B on Antibiotic-Resistant Proteus Mirabilis
- Total Synthesis of Malacidin a by Β‐Hydroxyaspartic Acid Ligation Mediated Cyclization and Absolute Structure Establishment
- Pocket Guide for Antibiotic Pharmacotherapy